This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Adynxx Sub, Inc., Adynxx, Inc., Jpmorgan Chase Bank, N.a.. Active years: 2013-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2020
Title: Scott Harris: Innovator in Pain Treatment and Active Ingredient Delivery
Introduction
Scott Harris is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of pain. With a total of 6 patents to his name, Harris continues to push the boundaries of innovation in his area of expertise.
Latest Patents
Harris's latest patents include groundbreaking work on oligonucleotide decoys for the treatment of pain. This invention provides therapeutic agents such as double-stranded nucleic acids, termed oligonucleotide decoys, along with pharmaceutical compositions that modulate nociceptive signaling to prevent and treat pain. Another significant patent focuses on formulations for the delivery of active ingredients. This invention relates to in vivo delivery of active ingredient formulations, particularly those that include an agent, along with methods for making and using these formulations.
Career Highlights
Throughout his career, Scott Harris has worked with prominent organizations, including JPMorgan Chase Bank and Adynxx, Inc. His experience in these companies has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Harris has collaborated with notable individuals in his field, including Julien Mamet and Rick Orr. These partnerships have fostered a creative environment that has led to the development of his impactful inventions.
Conclusion
Scott Harris exemplifies the spirit of innovation in the medical field, particularly in pain management and active ingredient delivery. His contributions through his patents and collaborations continue to influence the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile